Blue Trust Inc. grew its holdings in shares of CorVel Co. (NASDAQ:CRVL – Free Report) by 435.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 91 shares of the business services provider’s stock after buying an additional 74 shares during the quarter. Blue Trust Inc.’s holdings in CorVel were worth $30,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the business. SkyView Investment Advisors LLC grew its stake in shares of CorVel by 0.8% during the second quarter. SkyView Investment Advisors LLC now owns 4,284 shares of the business services provider’s stock valued at $1,089,000 after buying an additional 34 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in CorVel by 2.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,143 shares of the business services provider’s stock worth $545,000 after purchasing an additional 46 shares in the last quarter. Arizona State Retirement System grew its stake in CorVel by 1.8% in the second quarter. Arizona State Retirement System now owns 2,632 shares of the business services provider’s stock worth $669,000 after purchasing an additional 46 shares in the last quarter. GAMMA Investing LLC grew its stake in CorVel by 98.0% in the second quarter. GAMMA Investing LLC now owns 97 shares of the business services provider’s stock worth $25,000 after purchasing an additional 48 shares in the last quarter. Finally, Ellsworth Advisors LLC grew its stake in CorVel by 2.7% in the third quarter. Ellsworth Advisors LLC now owns 2,340 shares of the business services provider’s stock worth $765,000 after purchasing an additional 61 shares in the last quarter. Institutional investors own 51.36% of the company’s stock.
CorVel Stock Up 1.5 %
Shares of NASDAQ:CRVL opened at $302.14 on Friday. CorVel Co. has a 52-week low of $194.85 and a 52-week high of $329.23. The stock has a market cap of $5.18 billion, a P/E ratio of 66.99 and a beta of 1.10. The business’s 50 day moving average is $312.48 and its 200 day moving average is $282.87.
Analysts Set New Price Targets
Get Our Latest Research Report on CorVel
Insider Buying and Selling
In related news, CEO Michael G. Combs sold 2,473 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $300.99, for a total value of $744,348.27. Following the transaction, the chief executive officer now owns 16,823 shares of the company’s stock, valued at $5,063,554.77. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other CorVel news, CEO Michael G. Combs sold 2,473 shares of the company’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $300.99, for a total transaction of $744,348.27. Following the completion of the sale, the chief executive officer now owns 16,823 shares in the company, valued at $5,063,554.77. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director R Judd Jessup sold 2,131 shares of the company’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $295.21, for a total value of $629,092.51. Following the sale, the director now owns 43,277 shares of the company’s stock, valued at approximately $12,775,803.17. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 16,479 shares of company stock valued at $4,978,650 over the last quarter. 47.57% of the stock is owned by corporate insiders.
CorVel Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Read More
- Five stocks we like better than CorVel
- What Are Dividend Challengers?
- Battle of the Retailers: Who Comes Out on Top?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- How to Invest in Blue Chip Stocks
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Co. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.